---
title: "What Is TechBio?"
term: "TechBio"
description: "TechBio describes companies that apply software, machine learning, and automation to biology — drug discovery, synthetic biology, diagnostics, or lab workflows — rather than traditional small-molecule pharma alone."
date: 2026-07-25T00:00:00.000Z
updated: 2026-07-25T00:00:00.000Z
topics: ["venture-capital"]
source: https://venturecapitaltracker.com/glossary/techbio
---

# What Is TechBio?

> TechBio describes companies that apply software, machine learning, and automation to biology — drug discovery, synthetic biology, diagnostics, or lab workflows — rather than traditional small-molecule pharma alone.

**TechBio** refers to life-sciences companies where software, data, and automation are core to the product — not an afterthought bolted onto traditional drug development.

### How it works

Examples include AI-driven target discovery, cloud lab orchestration, CRISPR design tools, and diagnostics built on large multimodal datasets. Some TechBio firms license software to pharma; others run internal pipelines that produce drug candidates. Business models span SaaS subscriptions, usage-based lab fees, and milestone-heavy partnerships.

Investors compare TechBio to "biotech" (long FDA cycles, binary clinical outcomes) and "healthtech" (often care delivery or admin software). TechBio sits in the middle: deep science risk plus engineering velocity. Funding rounds may look like Series A software checks but diligence still covers IP, reproducibility, and regulatory path if therapeutics are in scope.

### Why it matters

- **Founders:** Position clearly — platform vs pipeline. Mixed stories confuse investors on valuation comps and capital intensity.
- **Investors:** TechBio diligence blends technical diligence on models and lab validation with standard biotech IP review. Unit economics differ sharply between tool vendors and IND-stage programs.

### Common mistake

Calling any biotech with a website "TechBio." Without proprietary data loops, automation, or computational moats, the label adds no investor clarity.

### Related ideas

See also [TRL (Technology Readiness Level)](/glossary/trl-technology-readiness-level), [technical diligence](/glossary/technical-diligence), synthetic biology, and computational drug discovery.

## FAQ

### What is TechBio in simple terms?

TechBio companies build products where biology meets software — using AI to design proteins, automate lab work, or analyze genomic data at scale. They often sell tools or platforms, not just single drugs.

### Why does TechBio matter?

VCs bucket TechBio differently from asset-heavy biotech: faster iteration, recurring revenue potential, but still regulatory and scientific risk. Founders should clarify whether they are a platform vendor or a therapeutic developer.


---
Source: https://venturecapitaltracker.com/glossary/techbio